Non-Covalently Pre-Assembled High-Performance Near-Infrared Fluorescent Molecular Probes for Cancer Imaging-Reference-Cited by-同舟云学术

Non-Covalently Pre-Assembled High-Performance Near-Infrared Fluorescent Molecular Probes for Cancer Imaging

Published:2018-08-19 Issue:52 Volume:24 Page:13821-13829
ISSN:0947-6539
Container-title:Chemistry - A European Journal
language:en
Short-container-title:Chem. Eur. J.

Author:

Shaw Scott K.¹,Liu Wenqi¹,Gómez Durán César Fernando Azael¹,Schreiber Cynthia L.¹,Betancourt Mendiola María de Lourdes¹,Zhai Canjia¹,Roland Felicia M.¹,Padanilam Simon J.¹,Smith Bradley D.¹^ORCID

Affiliation:

1. Department of Chemistry & Biochemistry; University of Notre Dame; 236 Nieuwland Science Hall Notre Dame IN 46545 USA

Funder

Office of Extramural Research, National Institutes of Health

Publisher

Wiley

Subject

General Chemistry,Catalysis,Organic Chemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/chem.201801825/fullpdf

Reference49 articles.

1. Advancing Biological Understanding and Therapeutics Discovery with Small-Molecule Probes

2. Tumor-targeting peptides from combinatorial libraries

3. Guidelines for the Synthesis of Small-Molecule Irreversible Probes Targeting G Protein-Coupled Receptors

4. Targeting biomolecules with reversible covalent chemistry

5. Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research Progress of Tetralactam Macrocycle-Based Molecular Recognition and Applications;Chinese Journal of Organic Chemistry;2024

2. A High‐Affinity “Synthavidin” Receptor for Squaraine Dyes;Angewandte Chemie International Edition;2023-10-25

3. A High‐Affinity “Synthavidin” Receptor for Squaraine Dyes;Angewandte Chemie;2023-10-25

4. A Review on Recent Advances in Peptide‐based Fluorescence Probes and their Potential Applications;ChemistrySelect;2023-08-17

5. Peptides for diagnosis and treatment of ovarian cancer;Frontiers in Oncology;2023-05-05